Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

43.06
Delayed Data
As of 4:02pm ET
 +0.46 / +1.08%
Today’s Change
32.76
Today|||52-Week Range
43.74
+7.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$2.2B

Company Description

Haemonetics Corp. operates as a global healthcare company, which engages in the provision of products for processing, handling, and analysis of blood. Its products are divided into four categories: Plasma, Blood Center, Hospital, and Software Solutions. The Plasma product line includes plasma collection market for fractionation and the company's plasma products. The Blood Center product line offers blood collection market for transfusion and the company's blood center products. The Hospital product line provides transfusion market for hospitals and the company's hospital products. The Software Solutions deals with the software products and services. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

Contact Information

Haemonetics Corp.
400 Wood Road
Braintree Massachusetts 02184-9114
P:(781) 848-7100
Investor Relations:
(781) 356-9402

Employees

Shareholders

Mutual fund holders62.36%
Other institutional43.22%
Individual stakeholders2.04%

Top Executives

Christopher SimonPresident, Chief Executive Officer & Director
Neil RydingExecutive Vice President-Global Operations
William P. BurkeChief Financial Officer
Dan GoldsteinChief Accounting Officer
Gerry GouldVice President-Investor Relations